Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Vaccine shows promise in preventing mono

Vaccine shows promise in preventing mono

December 11, 2007

A new study suggests that a vaccine targeting Epstein-Barr virus (EBV) may prevent infectious mononucleosis, commonly known as "mono" or "glandular fever." The study is published in the December 15 issue of The Journal of Infectious Diseases, now available online.

EBV is a member of the herpes virus family and one of the most common viruses in humans, with nearly all adults in developed countries such as the United States having been infected. EBV is often asymptomatic but commonly causes infectious mononucleosis, with 30 to 40 percent of adolescents who contract the virus developing the disease. EBV is also associated with a number of other diseases, some of the most serious being lymphomas and other lymphoproliferative diseases in people with compromised immune systems, such as transplant patients. Despite the frequency of EBV infections and infectious mononucleosis, the new study is the first to suggest the efficacy of a vaccine in preventing infectious mononucleosis.




The study was conducted by Etienne M. Sokal, MD, PhD, and colleagues at several Belgian institutions and pharmaceutical companies. The vaccine targets glycoprotein 350, a protein that facilitates the entry of EBV into immune system cells. In this preliminary, Phase II clinical trial, 181 young adults who had not previously been infected by EBV received three doses of either a placebo or the vaccine.

During the 18-month observation period, the proportion of symptomatic EBV infections was reduced from 10 percent (nine out of 91) in the control group to 2 percent (two out of 90) in the vaccinated group, indicating that those who did not receive the vaccine were almost 5 times more likely to develop infectious mononucleosis.

With these promising results in a small group of subjects, Dr. Sokal suggested the next step should be "large-scale studies on the benefit in healthy subjects and ability to prevent acute EBV infection and post-transplant lymphoproliferative diseases in transplant patients." He added, "There is currently no possibility to prevent or to treat acute mononucleosis, which has remained so far an unmet medical problem. This vaccine may decrease the socio-economic impact of acute mononucleosis."

Development of an EBV vaccine has had a slow and problematic history. These results suggest that the prevention of infectious mononucleosis is possible, and provide a framework for future trials looking to prevent more serious consequences of EBV infection.

In an accompanying editorial, Henry H. Balfour, Jr., MD, of the University of Minnesota Medical School, noted the importance of such studies on EBV vaccines, especially because "the worldwide disease burden due to EBV is enormous." Balfour agreed that these findings should stimulate future research and larger clinical trials on the prevention and treatment of diseases associated with EBV.

Infectious Diseases Society of America



Related Mononucleosis Current Events and Mononucleosis News Articles Mononucleosis Current Events and Mononucleosis News RSS Mononucleosis Current Events and Mononucleosis News RSS
Researchers find further evidence linking Epstein-Barr virus and risk of multiple sclerosis
Researchers from the Harvard School of Public Health, Walter Reed Army Institute of Research, and a team of collaborators have observed for the first time that the risk of multiple sclerosis (MS) increases by many folds following infection with the Epstein-Barr virus (EBV).

UCSF researchers identify new drug target for Kaposi's Sarcoma
UCSF researchers have identified a new potential drug target for the herpes virus that causes Kaposi's sarcoma, re-opening the possibility of using the class of drugs called protease inhibitors against the full herpes family of viruses, which for 20 years has been deemed too difficult to attain.

Study indicates that a common virus could cause high blood pressure
A new study suggests for the first time that cytomegalovirus (CMV), a common viral infection affecting between 60 and 99 percent of adults worldwide, is a cause of high blood pressure, a leading risk factor for heart disease, stroke and kidney disease.

Epstein-Barr Virus May Be Associated with Progression of MS
Epstein-Barr virus (EBV), the pathogen that causes mononucleosis, appears to play a role in the neurodegeneration that occurs in persons with multiple sclerosis, researchers at the University at Buffalo and the University of Trieste, Italy, have shown.

OHSU finds association between Epstein-Barr virus, inflammatory diseases of the mouth
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.

OHSU research suggests America may over-vaccinate
A new study published in the New England Journal of Medicine this week by Oregon Health & Science University researchers suggests that timelines for vaccinating and revaccinating Americans against disease should possibly be reevaluated and adjusted.

Epstein-Barr: a virtual look at a vexing virus
Researchers at Tufts University School of Medicine in collaboration with the Virginia Bioinformatics Institute at Virginia Tech have created a computer program called Pathogen Simulation (PathSim) to study the progression of Epstein-Barr virus (EBV) in humans.

An AIDS-related virus reveals more ways to cause cancer, Penn researchers find
Researchers at the University of Pennsylvania School of Medicine have shed new light on how Kaposi's Sarcoma-associated Herpes Virus (KSHV) subverts normal cell machinery to cause cancer.

Common blood test can help distinguish between mononucleosis and tonsillitis
Measuring a patient's ratio of white blood cell types may help physicians accurately distinguish between the similar conditions infectious mononucleosis and bacterial tonsillitis, potentially guiding treatment decisions.

New lab mice pave way for novel studies of human infection
A new type of laboratory mouse developed at UT Southwestern Medical Center can fight certain infections the same way humans do, making the rodents very useful for novel studies of human-pathogen interaction and developing disease therapies.
More Mononucleosis Current Events and Mononucleosis News Articles
Monobril Mononucleosis Mono (compare to Monobrex)

Monobril Mononucleosis Mono (compare to Monobrex)
by Neubrio Labs

Monobril (compare to Monobrex) is formulated to be a safe and effective way to get relief from sore throat and infections caused by mono after it has weakened your immune system. Monobril (compare to Monobrex) is completely all-natural, a safe blend of botanical extracts and vitamins that naturally assist your body in fighting infection. The only side affect is a quick recovery!

Mononucleosis (Deadly Diseases and Epidemics)

Mononucleosis (Deadly Diseases and Epidemics)
by Janet, Ph.D. Decker (Author), Alan Hecht (Author), Hilary, M.D. Babcock (Contributor)

Often called the 'kissing disease' due to its transmission through saliva, mononucleosis is a disease caused by the Epstein-Barr virus. Many are familiar with mononucleosis, by either having suffered from it themselves or knowing a friend who has. "Mononucleosis, Second Edition" explores the microbiology of the virus as well as treatment and prevention options. This revised edition provides updated information on current research and treatments as well as new illustrations. The chapters include: Infectious Mononucleosis and Epstein-Barr Virus, The Discovery of Epstein-Barr Virus, The Life of Epstein-Barr Virus, Immune System Response to Epstein-Barr Virus, Signs and Symptoms, Diagnosis of Infectious Mononucleosis, Treatments for Infectious Mononucleosis, Epstein-Barr Virus and Cancer,...

Infectious Mononucleosis (Diseases and Disorders)

Infectious Mononucleosis (Diseases and Disorders)
by Don Nardo (Author)



Mononucleosis

Mononucleosis
Ween (Primary Contributor)



Remel Color Slide II Mononucleosis Latex Test Kit Seradyn Color

Remel Color Slide II Mononucleosis Latex Test Kit Seradyn Color
by Fisher Scientific

CPT Code: 86308. Complexity: Non-waived. Red blood cell agglutination. Test results within 60 seconds. Uses specially treated horse erythrocytes to enhance the specificity, sensitivity and readability of the results. Provides clear, "yes/no" results. Kits contain disposable plastic pipettes for convenient pipetting and stirring, disposable slides, plus positive and negative controls. Pack of 50.

  Support for Mononucleosis - 60 Cap Bottle
by Universal Naturals

Supports the body in combating the effects of mononucleosis.

Mononucleosis (Health Alert (Benchmark Books).)

Mononucleosis (Health Alert (Benchmark Books).)
by Gretchen Hoffmann (Author)



Sealed with a Kiss

Sealed with a Kiss
Also With: Linda Schuyler (Producer)



  Support for Mononucleosis - 600 Cap Bottle
by Universal Naturals

Supports the body in combating the effects of mononucleosis.

Mononucleosis

Mononucleosis
Speedking (Primary Contributor)



© 2010 BrightSurf.com